"Designing Growth Strategies is in our DNA"

Diabetic Neuropathy Market Size, Share & Industry Analysis, By Disease Type (Peripheral, Autonomic, Proximal, and Focal), By Drug Class (Anti-Depressants, Anti-Seizures, Opioid, Non-Steroidal Anti-Inflammatory, and others), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100598

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
    2. New Product Launches
    3. Prevalence of Diabetic Neuropathy
    4. Pipeline Analysis
  5. Global Diabetic Neuropathy Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. Peripheral
      2. Autonomic
      3. Proximal
      4. Focal
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-Steroidal Anti-Inflammatory Drugs
      2. Opioid
      3. Anti-Depressants
      4. Anti-Seizure
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Diabetic Neuropathy Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Peripheral
      2. Autonomic
      3. Proximal
      4. Focal
    3. Market Analysis – By Drug Class
      1. Non-Steroidal Anti-Inflammatory Drugs
      2. Opioid
      3. Anti-Depressants
      4. Anti-Seizure
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Diabetic Neuropathy Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Peripheral
      2. Autonomic
      3. Proximal
      4. Focal
    3. Market Analysis – By Drug Class
      1. Non-Steroidal Anti-Inflammatory Drugs
      2. Opioid
      3. Anti-Depressants
      4. Anti-Seizure
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Diabetic Neuropathy Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Peripheral
      2. Autonomic
      3. Proximal
      4. Focal
    3. Market Analysis – By Drug Class
      1. Non-Steroidal Anti-Inflammatory Drugs
      2. Opioid
      3. Anti-Depressants
      4. Anti-Seizure
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Diabetic Neuropathy Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Peripheral
      2. Autonomic
      3. Proximal
      4. Focal
    3. Market Analysis – By Drug Class
      1. Non-Steroidal Anti-Inflammatory Drugs
      2. Opioid
      3. Anti-Depressants
      4. Anti-Seizure
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Diabetic Neuropathy Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Peripheral
      2. Autonomic
      3. Proximal
      4. Focal
    3. Market Analysis – By Drug Class
      1. Non-Steroidal Anti-Inflammatory Drugs
      2. Opioid
      3. Anti-Depressants
      4. Anti-Seizure
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. Abbott
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Eli Lilly and Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Pfizer.Inc
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. GlaxoSmithKline plc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Lupin Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Astellas Pharma US, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Diabetic Neuropathy Market Revenue Breakdown (US$ Bn, %) by Region, 2018 & 2026

Figure 2:  Global Diabetic Neuropathy Market Value Share (%), by Disease Type, 2018 & 2026

Figure 3:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Peripheral, 2015-2026

Figure 4:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Autonomic, 2015-2026

Figure 5:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Proximal, 2015-2026

Figure 6:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Focal, 2015-2026

Figure 7:  Global Diabetic Neuropathy Market Value Share (%), by Drug Class, 2018 & 2026

Figure 8:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Non-Steroidal Anti-Inflammatory Drugs, 2015-2026

Figure 9:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Opioid, 2015-2026

Figure 10:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Anti-Depressants, 2015-2026

Figure 11:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Anti-Seizure, 2015-2026

Figure 12:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Others, 2015-2026

Figure 13:  Global Diabetic Neuropathy Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 14:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Hospitals Pharmacies, 2015-2026

Figure 15:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Retail Pharmacies & Stores, 2015-2026

Figure 16:  Global Diabetic Neuropathy Market Forecast (US$ Bn), by Online Pharmacies, 2015-2026

Figure 17:  Global Diabetic Neuropathy Market Value (US$ Bn), by Region, 2018 & 2026

Figure 18:  North America Diabetic Neuropathy Market Value (US$ Bn), by Disease Type, 2018 & 2026

Figure 19:  North America Diabetic Neuropathy Market Value Share (%), by Disease Type, 2018

Figure 20:  North America Diabetic Neuropathy Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 21:  North America Diabetic Neuropathy Market Value Share (%), by Drug Class, 2018

Figure 22:  North America Diabetic Neuropathy Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 23:  North America Diabetic Neuropathy Market Value Share (%), by Distribution Channel, 2018

Figure 24:  North America Diabetic Neuropathy Market Value (US$ Bn), By Country, 2018 & 2026

Figure 25:  North America Diabetic Neuropathy Market Value Share (%), By Country, 2018

Figure 26:  Europe Diabetic Neuropathy Market Value (US$ Bn), by Disease Type, 2018 & 2026

Figure 27:  Europe Diabetic Neuropathy Market Value Share (%), by Disease Type, 2018

Figure 28:  Europe Diabetic Neuropathy Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 29:  Europe Diabetic Neuropathy Market Value Share (%), by Drug Class, 2018

Figure 30:  Europe Diabetic Neuropathy Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 31:  Europe Diabetic Neuropathy Market Value Share (%), by Distribution Channel, 2018

Figure 32:  Europe Diabetic Neuropathy Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 33:  Europe Diabetic Neuropathy Market Value Share (%), By Country/ Sub-region, 2018

Figure 34:  Asia Pacific Diabetic Neuropathy Market Value (US$ Bn), by Disease Type, 2018 & 2026

Figure 35:  Asia Pacific Diabetic Neuropathy Market Value Share (%), by Disease Type, 2018

Figure 36:  Asia Pacific Diabetic Neuropathy Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 37:  Asia Pacific Diabetic Neuropathy Market Value Share (%), by Drug Class, 2018

Figure 38:  Asia Pacific Diabetic Neuropathy Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 39:  Asia Pacific Diabetic Neuropathy Market Value Share (%), by Distribution Channel, 2018

Figure 40:  Asia Pacific Diabetic Neuropathy Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 41:  Asia Pacific Diabetic Neuropathy Market Value Share (%), By Country/ Sub-region, 2018

Figure 42:  Latin America Diabetic Neuropathy Market Value (US$ Bn), by Disease Type, 2018 & 2026

Figure 43:  Latin America Diabetic Neuropathy Market Value Share (%), by Disease Type, 2018

Figure 44:  Latin America Diabetic Neuropathy Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 45:  Latin America Diabetic Neuropathy Market Value Share (%), by Drug Class, 2018

Figure 46:  Latin America Diabetic Neuropathy Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 47:  Latin America Diabetic Neuropathy Market Value Share (%), by Distribution Channel, 2018

Figure 48:  Latin America Diabetic Neuropathy Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 49:  Latin America Diabetic Neuropathy Market Value Share (%), By Country/ Sub-region, 2018

Figure 50:  Middle East & Africa Diabetic Neuropathy Market Value (US$ Bn), by Disease Type, 2018 & 2026

Figure 51:  Middle East & Africa Diabetic Neuropathy Market Value Share (%), by Disease Type, 2018

Figure 52:  Middle East & Africa Diabetic Neuropathy Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 53:  Middle East & Africa Diabetic Neuropathy Market Value Share (%), by Drug Class, 2018

Figure 54:  Middle East & Africa Diabetic Neuropathy Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 55:  Middle East & Africa Diabetic Neuropathy Market Value Share (%), by Distribution Channel, 2018

Figure 56:  Middle East & Africa Diabetic Neuropathy Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 57:  Middle East & Africa Diabetic Neuropathy Market Value Share (%), By Country/ Sub-region, 2018

Figure 58:  Global Diabetic Neuropathy Market Share (%), By Company, 2018

Table 1:  Global Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Disease Type, 2015–2026

Table 2:  Global Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Drug Class, 2015–2026

Table 3:  Global Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Region, 2015-2026

Table 5:  North America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Disease Type, 2015-2026

Table 6:  North America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 7:  North America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, By Country, 2015-2026

Table 9:  Europe Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Disease Type, 2015-2026

Table 10:  Europe Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 11:  Europe Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Disease Type, 2015-2026

Table 14:  Asia Pacific Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 15:  Asia Pacific Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Disease Type, 2015-2026

Table 18:  Latin America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 19:  Latin America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Disease Type, 2015-2026

Table 22:  Middle East & Africa Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 23:  Middle East & Africa Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Diabetic Neuropathy Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Diabetic Neuropathy Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase